Literature DB >> 10393472

Signal transduction pathways associated with alpha1-adrenoceptor subtypes in cells and tissues including human prostate.

I Marshall1, R P Burt, C R Chapple.   

Abstract

The complexity of the signal transduction pathways linked to alpha1A-adrenoceptors are becoming clearer. At one time it was thought that the alpha1A-subtype was linked to the influx of extracellular Ca2+ while the alpha1B-subtype was linked via inositol phosphate formation to the release of intracellular Ca2. However the coupling of the alpha1-adrenoceptors to G-proteins leads to the activation of a number of different effector enzymes which produce intracellular second messengers and alterations in biological activity. One area of diversity is in the many forms of the Galpha, beta, gamma heterotrimeric G-proteins which confer specificity towards certain effectors. All alpha1-adrenoceptor subtypes have been shown to couple to phospholipase C in many cells and tissues leading to the breakdown of PiP2 to give IP3, which releases intracellular Ca2+, and diacylglycerol, which stimulates protein kinase C. Additional effectors which can couple to alpha1-adrenoceptors include phospholipase D, adenylate cyclase and the mitogen-activated protein kinase pathway. The latter involves a longer term response and causes increased cell growth and may be important in, for example, the prostate as well as in vascular smooth muscle and the heart. In human prostate alpha1-adrenoceptor activation leads to the release of intracellular Ca2+ from ryanodine-sensitive store followed by an influx of extracellular Ca2+, a mechanism different from that linked to the same receptor subtype in several other smooth muscles. Therefore a given alpha1-subtype may be coupled to a variety of different signal transduction mechanisms in different systems. Further, there may be different effector mechanisms linked to alpha1-subtypes in a given cell or tissue e.g. phospholipase C and mitogen-activated protein kinase. An increased understanding of the complexity of signal transduction mechanisms and the elucidation of the details in a particular tissue will open up new possibilities for therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393472     DOI: 10.1159/000052317

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  7 in total

1.  Receptor-coupled, DAG-gated Ca2+-permeable cationic channels in LNCaP human prostate cancer epithelial cells.

Authors:  V Sydorenko; Y Shuba; S Thebault; M Roudbaraki; G Lepage; N Prevarskaya; R Skryma
Journal:  J Physiol       Date:  2003-05-01       Impact factor: 5.182

2.  Alpha1-adrenergic receptors activate Ca(2+)-permeable cationic channels in prostate cancer epithelial cells.

Authors:  Stephanie Thebault; Morad Roudbaraki; Vadim Sydorenko; Yaroslav Shuba; Loic Lemonnier; Christian Slomianny; Etienne Dewailly; Jean-Louis Bonnal; Brigitte Mauroy; Roman Skryma; Natalia Prevarskaya
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

3.  Noradrenergic vasoconstriction of pig prostatic small arteries.

Authors:  Paz Recio; Luis M Orensanz; María Pilar Martínez; Jorge Navarro-Dorado; Salvador Bustamante; Albino García-Sacristán; Dolores Prieto; Medardo Hernández
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-03       Impact factor: 3.000

4.  Activation of alpha-1 adrenergic receptors increases cytosolic calcium in neurones of the paraventricular nucleus of the hypothalamus.

Authors:  William J Milanick; Luis Polo-Parada; Heather A Dantzler; David D Kline
Journal:  J Neuroendocrinol       Date:  2019-10-13       Impact factor: 3.627

5.  Alpha 1-adrenoceptor effects mediated by protein kinase C alpha in human cultured prostatic stromal cells.

Authors:  A Preston; J M Haynes
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

Review 6.  Noradrenergic Modulation of Fear Conditioning and Extinction.

Authors:  Thomas F Giustino; Stephen Maren
Journal:  Front Behav Neurosci       Date:  2018-03-13       Impact factor: 3.558

7.  Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation.

Authors:  Maria Beatrice Morelli; Consuelo Amantini; Massimo Nabissi; Sonia Liberati; Claudio Cardinali; Valerio Farfariello; Daniele Tomassoni; Wilma Quaglia; Alessandro Piergentili; Alessandro Bonifazi; Fabio Del Bello; Matteo Santoni; Gabriele Mammana; Lucilla Servi; Alessandra Filosa; Angela Gismondi; Giorgio Santoni
Journal:  BMC Cancer       Date:  2014-12-07       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.